DJIA53417.16 140.15
S&P 5007652.86 -21.51
NASDAQ25980.19 -200.26
Russell 20003019.70 15.60
German DAX26106.60 -29.96
FTSE 10010854.32 37.76
CAC 408453.01 -31.42
EuroStoxx 506449.15 -16.50
Nikkei 22565856.43 328.34
Hang Seng25517.33 -492.13
Shanghai Comp3882.01 -23.19
KOSPI6696.96 0.00
Bloomberg Comm IDX139.38 -0.87
WTI Crude-fut85.91 -2.23
Brent Crude-fut82.38 -2.70
Natural Gas2.77 -0.04
Gasoline-fut2.94 -0.04
Gold-fut4689.70 -28.80
Silver-fut67.86 -1.32
Platinum-fut1853.40 -44.50
Palladium-fut1327.50 -35.50
Copper-fut673.60 2.60
Aluminum-spot3195.00 0.00
Coffee-fut331.65 -10.00
Soybeans-fut1217.75 -6.50
Wheat-fut690.00 -9.50
Bitcoin78903.88 184.39
Ethereum USD2467.70 -7.47
Litecoin51.22 -0.22
Dogecoin0.09 0.00
EUR/USD1.1664 -0.0010
USD/JPY159.34 0.37
GBP/USD1.3627 -0.0014
USD/CHF0.8033 0.0015
USD IDX99.01 0.01
US 10-Yr TR4.661 -0.043
GER 10-Yr TR3.2208 -0.0257
UK 10-Yr TR5.0106 -0.0485
JAP 10-Yr TR2.895 0.003
Fed Funds3.75 0
SOFR3.65 0
High-rise commercial buildings

Sub Markets

Topics

Alternative Assets  + VC  | 
Venture Firm B Capital Makes Bet on Healthcare with $500M Debut Fund

Venture Firm B Capital Makes Bet on Healthcare with $500M Debut Fund

B Capital, a NYC- and Singapore-based global multi-stage venture firm, has closed its $500 million debut Healthcare Fund I that hunts for opportunities in the healthcare sector.

The new fund kicked off when Dr Robert Mittendorff joined B Capital as General Partner in April 2021 to lead the fund and its global healthcare initiatives. The firm aims to double down on opportunities across health tech, digital health, biotech and medtech verticals with the new capital.

“Technological advancements in biology, AI and automation are transforming the industry, with business models seeing the convergence of traditional players in novel ways,” said Robert Mittendorff, Managing Director, General Partner, and Head of Healthcare at B Capital.

The healthcare sector is not new to B Capital, which has built a global portfolio of 20 firms across the US, Asia and Europe spanning early- to late-stage investments, including Hotspot Therapeutics, Triumvira and CapitalRX.

B Capital’s healthcare fund follows the close of Growth Fund III in January at $2.1 billion. With the close of these funds, the firm’s total assets under management are approximately $6.3 billion.

Founded by Raj Ganguly and Facebook co-founder Eduardo Saverin in 2014, the firm has an integrated team across nine locations in the US and Asia and a strategic partnership with Boston Consulting Group to expand into new markets and support entrepreneurs across all growth stages.

Connect

Inside The Story

B Capital

About Joe Palmisano

Joe Palmisano is Editorial Director for Connect Money, where he brings nearly three decades experience of market insights as a financial journalist, analyst and senior portfolio manager for leading financial publications, advisory firms, and hedge funds. In his role as Editorial Director, Joe is responsible for the selection of content and creation of daily business news covering the financial markets, including Alternative Assets, Direct Investment and Financial Advisory services. Before joining Connect Money, Joe was a financial journalist for the Wall Street Journal, regularly publishing feature stories and trend pieces on the foreign exchange, global fixed income and equity markets. Joe parlayed his experience as a financial journalist into roles as a Senior Research Analyst and Portfolio Manager, writing daily and weekly market analysis and managing a FX and US equity portfolio. Joe was also a contributing writer for industry magazines and publications, including SFO Magazine and the CMT Association. Joe earned a B.S.B.A. in Finance from The American University. He holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.

New call-to-action
New call-to-action